Susquehanna International Group, LLP Generation Bio Co. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Generation Bio Co. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 92,248 shares of GBIO stock, worth $34,131. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,248
Previous 22,788
304.81%
Holding current value
$34,131
Previous $24,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding GBIO
# of Institutions
82Shares Held
42.8MCall Options Held
70.4KPut Options Held
700-
Price T Rowe Associates Inc Baltimore, MD9.06MShares$3.35 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC8.28MShares$3.06 Million0.97% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$1.22 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.97MShares$1.1 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.62MShares$969,2920.0% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $21.8M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...